Literature DB >> 32461673

Risk factors for death from COVID-19.

Myvizhi Esai Selvan1.   

Abstract

Entities:  

Year:  2020        PMID： 32461673      PMCID： PMC7251559          DOI： 10.1038/s41577-020-0351-0

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  15 in total

1.  Bayesian spatial modeling of COVID-19 case-fatality rate inequalities.

Authors:  Gina Polo; Diego Soler-Tovar; Luis Carlos Villamil Jimenez; Efraín Benavides-Ortiz; Carlos Mera Acosta
Journal:  Spat Spatiotemporal Epidemiol       Date:  2022-03-25

2.  Using behavioural theory to understand adherence to behaviours that reduce transmission of COVID-19; evidence from the CHARIS representative national study.

Authors:  Diane Dixon; Chantal Den Daas; Gill Hubbard; Marie Johnston
Journal:  Br J Health Psychol       Date:  2021-05-17

3.  Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.

Authors:  Tingxuan Gu; Simin Zhao; Guoguo Jin; Mengqiu Song; Yafei Zhi; Ran Zhao; Fayang Ma; Yaqiu Zheng; Keke Wang; Hui Liu; Mingxia Xin; Wei Han; Xiang Li; Christopher D Dong; Kangdong Liu; Zigang Dong
Journal:  Front Immunol       Date:  2021-01-28       Impact factor: 7.561

4.  Characteristics, outcomes and risk factors for mortality of 522 167 patients hospitalised with COVID-19 in Brazil: a retrospective cohort study.

Authors:  Marcia C Castro; Susie Gurzenda; Eduardo Marques Macário; Giovanny Vinícius A França
Journal:  BMJ Open       Date:  2021-05-04       Impact factor: 2.692

5.  Microscopic dynamics modeling unravels the role of asymptomatic virus carriers in SARS-CoV-2 epidemics at the interplay between biological and social factors.

Authors:  Bosiljka Tadić; Roderick Melnik
Journal:  Comput Biol Med       Date:  2021-04-24       Impact factor: 6.698

6.  COVID-19 stressors and health behaviors: A multilevel longitudinal study across 86 countries.

Authors:  Shian-Ling Keng; Michael V Stanton; LeeAnn B Haskins; Carlos A Almenara; Jeannette Ickovics; Antwan Jones; Diana Grigsby-Toussaint; Maximilian Agostini; Jocelyn J Bélanger; Ben Gützkow; Jannis Kreienkamp; Edward P Lemay; Michelle R vanDellen; Georgios Abakoumkin; Jamilah Hanum Abdul Khaiyom; Vjollca Ahmedi; Handan Akkas; Mohsin Atta; Sabahat Cigdem Bagci; Sima Basel; Edona Berisha Kida; Allan B I Bernardo; Nicholas R Buttrick; Phatthanakit Chobthamkit; Hoon-Seok Choi; Mioara Cristea; Sára Csaba; Kaja Damnjanovic; Ivan Danyliuk; Arobindu Dash; Daniela Di Santo; Karen M Douglas; Violeta Enea; Daiane G Faller; Gavan Fitzsimons; Alexandra Gheorghiu; Ángel Gómez; Ali Hamaidia; Qing Han; Mai Helmy; Joevarian Hudiyana; Bertus F Jeronimus; Ding-Yu Jiang; Veljko Jovanović; Željka Kamenov; Anna Kende; Tra Thi Thanh Kieu; Yasin Koc; Kamila Kovyazina; Inna Kozytska; Joshua Krause; Arie W Kruglanski; Anton Kurapov; Maja Kutlaca; Nóra Anna Lantos; Cokorda Bagus Jaya Lesmana; Winnifred R Louis; Adrian Lueders; Marta Maj; Najma Iqbal Malik; Anton Martinez; Kira O McCabe; Jasmina Mehulić; Mirra Noor Milla; Idris Mohammed; Erica Molinario; Manuel Moyano; Hayat Muhammad; Silvana Mula; Hamdi Muluk; Solomiia Myroniuk; Reza Najafi; Claudia F Nisa; Boglárka Nyúl; Paul A O'Keefe; Jose Javier Olivas Osuna; Evgeny N Osin; Joonha Park; Gennaro Pica; Antonio Pierro; Jonas Rees; Anne Margit Reitsema; Elena Resta; Marika Rullo; Michelle K Ryan; Adil Samekin; Pekka Santtila; Edyta M Sasin; Birga M Schumpe; Heyla A Selim; Wolfgang Stroebe; Samiah Sultana; Robbie M Sutton; Eleftheria Tseliou; Akira Utsugi; Jolien Anne van Breen; Caspar J Van Lissa; Kees Van Veen; Alexandra Vázquez; Robin Wollast; Victoria Wai-Lan Yeung; Somayeh Zand; Iris Lav Žeželj; Bang Zheng; Andreas Zick; Claudia Zúñiga; N Pontus Leander
Journal:  Prev Med Rep       Date:  2022-03-17

7.  Rationale and design of the "Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled" trial (TOCIBRAS).

Authors:  Danielle Leão Cordeiro de Farias; João Prats; Alexandre Biasi Cavalcanti; Regis Goulart Rosa; Flávia Ribeiro Machado; Otávio Berwanger; Luciano César Pontes de Azevedo; Renato Delascio Lopes; Álvaro Avezum; Leticia Kawano-Dourado; Lucas Petri Damiani; Salomón Soriano Ordinola Rojas; Cleyton Zanardo de Oliveira; Luis Eduardo Coelho Andrade; Alex Freire Sandes; Maria Carolina Pintão; Claudio Galvão de Castro Júnior; Phillip Scheinberg; Viviane Cordeiro Veiga
Journal:  Rev Bras Ter Intensiva       Date:  2020 Jul-Sep

Review 8.  AI-based language models powering drug discovery and development.

Authors:  Zhichao Liu; Ruth A Roberts; Madhu Lal-Nag; Xi Chen; Ruili Huang; Weida Tong
Journal:  Drug Discov Today       Date:  2021-06-30       Impact factor: 7.851

9.  Diphtheria And Tetanus Vaccination History Is Associated With Lower Odds of COVID-19 Hospitalization.

Authors:  Jennifer Monereo-Sánchez; Jurjen J Luykx; Justo Pinzón-Espinosa; Geneviève Richard; Ehsan Motazedi; Lars T Westlye; Ole A Andreassen; Dennis van der Meer
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

10.  Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19.

Authors:  Julie C Wilson; David Kealy; Sally R James; Tobias Plowman; Katherine Newling; Christopher Jagger; Kara Filbey; Elizabeth R Mann; Joanne E Konkel; Madhvi Menon; Sean B Knight; Angela Simpson; Aliya Prihartadi; Greg Forshaw; Neil Todd; David R A Yates; John R Grainger; Tracy Hussell; Paul M Kaye; Nathalie Signoret; Dimitris Lagos
Journal:  iScience       Date:  2021-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.